Albuminuria response to very high-dose valsartan in type 2 diabetes mellitus.

ObjectiveRenin–angiotensin system blockade is now standard in the management of the patient with type 2 diabetes mellitus. We aimed to investigate whether high doses of valsartan, an angiotensin receptor blocker, are superior to conventional doses to reduce urinary albumin excretion rates (UAER) in